in

Drug distribution and medical service company: Cardinal Health (CAH) (1979)

Cardinal Health Group (or translation: Cardinal Health, Cardinal Health, Cardinal Health, Cardinal Health) was founded in 1979 and is headquartered in Dublin, Ohio, with global employees With 50,200 employees, it is a holding company, mainly for the distribution of medicines and the provision of medication-related services, and the service targets are the healthcare industry.

Cardinal Health CAH Logo

Cardinal Health/Cardinal Medicine—Cardinal Health (CAH):

Cardinal Health is a Fortune Global 500 healthcare service company and the 14th largest income-generating company in the United States. The company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also produces medical and surgical products, including gloves, surgical gowns and fluid management products. In addition, it also operates the largest radiopharmaceutical network in the United States. Cardinal Health provides medical products to more than 75% of hospitals in the United States.

Cardinal Health is a global top 100 company, a multinational group specializing in the global sales of health nutrition, health food research, production and medical health. Now the world’s top scientific academies in the fields of health and nutrition, biology and world-renowned international biologists have carried out extensive technical cooperation, and have developed a new generation of health nutrition series that is world-renowned and internationally leading. And using the most advanced biological gene purification technology in the world today, the activity of extracting nutrients is preserved to the greatest extent. This series of products has established sales outlets in more than 100 countries and regions around the world, mainly in the United States, European Union countries, Canada, Japan, Singapore, etc.

American Cardinal products won the highest international quality evaluation: the world’s largest manufacturer and sales of nutritional and health products.

  • 1. Health care production business
  • ⑴ Product development, production and packaging services: drug transportation formation/development; joint production; traditional packaging; basic packaging for processing.
  • ⑵ Sales service: drug sales; surgical treatment and experiment; special product sales.
  • ⑶ Market and retail services: repayment services; joint sales.
  • 2. Health care provider business
  • ⑴ Product development, production and packaging services: surgical medical products; medicine repackaging.
  • ⑵ Sales service: drug sales; surgical medical sales; experiment; special product sales.
  • ⑶ Market and retail services: drug franchise; drug welfare management; spontaneous drug cooperation; information services.
  • ⑷ Medical improvement services: automatic drug supply; distribution system; consulting services; information services; employee business; drug management.

Cardinal Health/Cardinal Medical—Cardinal Health (CAH) financial status:

Note: Except the unit of stock price is USD, other currency units are: USD million

years

income

profit

Total assets

share price

Number of employees

2005

72,666

4,460

21,838

33.48

2006

79,664

4,814

23,433

38.32

2007

86,755

5,197

23,154

38.62

2008

87,408

3,777

23,448

28.75

2009

95,992

3,748

25,119

21.10

2010

98,503

3,781

19,990

28.37

2011

102,644

4,162

22,846

35.90

2012

107,552

4,541

24,260

35.61

2013

101,093

4,921

25,819

45.20

33,600

2014

91,084

5,161

26,033

65.92

34,000

2015

102,531

5,712

30,142

79.39

34,500

2016

121,546

6,543

34,122

74.14

37,300

2017

129,976

6,544

40,112

69.22

40,400

2018

136,809

7,181

39,951

57.47

50,200

Cardinal Health/Cardinal Medicine—Cardinal Health History:

  • In 1971, Robert D. Walter founded Cardinal Foods Company;
  • In 1979, the US food sales business merged into a few large domestic food companies, which restricted the group’s continued development. Walter and his collaborators turned their attention to drug sales, and Cardinal bought Ohio State. A pharmaceutical sales company in Zanesville, which later developed into a Cardinal sales company, marking Cardinal’s formal entry into the US pharmaceutical sales industry;
  • In 1983, Cardinal began a public enterprise.
  • During the 10 years from 1973 to 1983, Cardina Pharmaceuticals acquired more than 10 pharmaceutical sales companies across the United States;
  • In 1987, the pharmaceutical sales business doubled that of the food sales business;
  • In 1988, Cardinal sold the department responsible for food sales and completely transferred the group’s business to pharmaceutical sales;
  • In 1991, Cardinal’s operating income reached US$1 billion for the first time;
  • In 1994, Cardinal’s annual sales reached USD 6 billion;
  • In 1995, Cardina acquired the Medicine Shoppe International chain pharmacy in St. Louis, becoming the world’s largest drug distributor;
  • In 1999, Cardinal acquired Liberia Feite Biopharma International. Since then, Cardinal has successively acquired a number of companies, including: Pyxis for automatic supply and drug sales, Owen Health Care for hospital drug management, International Shoppe drug company with drug franchise rights, drug transportation channel development and joint production RP Scherer company, Allegiance company that produces and sells surgical medical products;
  • In 2003, Cardinal Health Group entered the medical and healthcare industries in Hong Kong, Taiwan and Macau;
  • In 2007, Cardinal Health Group ranked 51st in the global rankings of Fortune;
  • In 2009, Cardinal Health’s turnover was close to 100 billion US dollars;
  • In 2010, Cardinal Health Group ranked 43rd in the world’s top 500 rankings;
  • In 2010, Cardina Pharmaceuticals acquired Yongyu Pharmaceutical Management Company, one of China’s largest drug importers, for US$470 million to expand its business in China. This acquisition is also the first major investment in Asia by a large US drug wholesale company;
  • In July 2015, Cardina Pharmaceuticals acquired Harvard Drug Group (Harvard Drug Group) for approximately US$1.12 billion to expand its product line of generic and over-the-counter drugs;
  • On April 5, 2017, Cardinal Health acquired Medtronic ’s Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency (Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency) business for US$6.1 billion .
Subscribe
Notify of
0 Comments
Inline Feedbacks
View all Intels

Lifestyle retail chain: Boot Barn Holdings, Inc. (BOOT)

Anticancer drug company: Curis, Inc. (CRIS) (2000)